Search
Immunology_Partnering_Interests_2018-12.pdf
Oncology_Partnering_Interests-2018-12.pdf
RBB_Partnering_Interests-2018-12.pdf
Respiratory_Partnering_Interests_2018-12.pdf
Technologies_Partnering_Interests-2018-12.pdf
Partnering in Technologies HP SEPT 2024 CORP_0.pdf
Partnering in Technologies AH MAY 2024 CORP.pdf
Partnering in Oncology & Cancer Imm HP OCTOBER 2024 CORP.pdf
Partnering in Retinal Health HP OCTOBER 2024 CORP_1.pdf
Partnering in RBB HP OCTOBER CORP.pdf
Partnering in Biotherapeutics HP OCTOBER 2024 CORP_1.pdf
Partnering in Technologies HP OCTOBER 2024 CORP.pdf
Partnering in Mental Health Disorders HP OCTOBER 2024 CORP.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
Partnering with Boehringer Ingelheim HP OCTOBER 2024 CORP.pdf
Partnering in Immunology & Resp HP OCTOBER 2024 CORP.pdf
Research Collaborations
Research Collaborations
Clinical Collaborations
Clinical Collaborations
New partnership to develop schizophrenia treatments
Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments
Our Health and Safety initiative - BE SAFE
Health and safety are of great importance to Boehringer Ingelheim.
Animal Health Innovation
Animal Health Innovation
Water harvesting sytems for underserved communities
Many families in Mexico don’t have access to clean water. That affects their health. We help by financing and installing water harvesting systems.
Henke-Sass Wolf develop needle free device
Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs
Survey with Ipsos to gain insights human-animal bond
Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.